Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Pratt

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Open Forum Infectious Diseases|December 15, 2022
Factors Associated With Receiving Longer Than Recommended Therapy Among Culture-Negative Pulmonary Tuberculosis PatientsClarisse A Tsang, Neha N Patel, Jason E Stout, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2014
Trends in tuberculosis - United States, 2013Negar Niki Alami, Courtney M Yuen, Roque Miramontes, et al.
American Journal of Public Health|March 20, 2010
Tuberculosis among persons born in the Philippines and living in the United States, 2000-2007Lilia Ponce Manangan, Catheryn Jumao-as Salibay, Ryan MacLaren Wallace, et al.
Journal of Neurochemistry|December 24, 2003
CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamineAnindita Ganguly, Tinmarla Frances Oo, Margarita Rzhetskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2017
Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014Sarah E Smith, Robert Pratt, Lisa Trieu, et al.
Thorax|February 25, 2016
Mind the gap: TB trends in the USA and the UK, 2000-2011Chimeremma D Nnadi, Laura F Anderson, Lori R Armstrong, et al.
Journal of Public Health Management and Practice : JPHMP|April 15, 2006
Health department costs of managing persons with suspected and noncounted tuberculosis in New York City, Three Texas counties, and MassachusettsLilia P Manangan, Marisa Moore, Michelle Macaraig, et al.
Equity Neuroscience|September 25, 2025
Opportunities in stroke care at safety net hospitals: A socioecological perspectiveAnjail Sharrief, Joshua Wollen, Maha Almohamad, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureasTerance Hart, Alba T Macias, Karen Benwell, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|December 15, 2022
Factors Associated With Receiving Longer Than Recommended Therapy Among Culture-Negative Pulmonary Tuberculosis PatientsClarisse A Tsang, Neha N Patel, Jason E Stout, et al.
MMWR. Morbidity and Mortality Weekly Report|March 21, 2014
Trends in tuberculosis - United States, 2013Negar Niki Alami, Courtney M Yuen, Roque Miramontes, et al.
American Journal of Public Health|March 20, 2010
Tuberculosis among persons born in the Philippines and living in the United States, 2000-2007Lilia Ponce Manangan, Catheryn Jumao-as Salibay, Ryan MacLaren Wallace, et al.
Journal of Neurochemistry|December 24, 2003
CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamineAnindita Ganguly, Tinmarla Frances Oo, Margarita Rzhetskaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2017
Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014Sarah E Smith, Robert Pratt, Lisa Trieu, et al.
Thorax|February 25, 2016
Mind the gap: TB trends in the USA and the UK, 2000-2011Chimeremma D Nnadi, Laura F Anderson, Lori R Armstrong, et al.
Journal of Public Health Management and Practice : JPHMP|April 15, 2006
Health department costs of managing persons with suspected and noncounted tuberculosis in New York City, Three Texas counties, and MassachusettsLilia P Manangan, Marisa Moore, Michelle Macaraig, et al.
Equity Neuroscience|September 25, 2025
Opportunities in stroke care at safety net hospitals: A socioecological perspectiveAnjail Sharrief, Joshua Wollen, Maha Almohamad, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureasTerance Hart, Alba T Macias, Karen Benwell, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activityStephen D Roughley, Helen Browne, Alba T Macias, et al.
Pageof 4